M Douglas Ris1,2, Wendy M Leisenring3,4, Pamela Goodman3, Chongzhi Di3, Jennie Noll5, Wendy Levy1,2, Leslie L Robison6, Gregory T Armstrong6. 1. Department of Pediatrics, Baylor College of Medicine, Houston, Texas. 2. Texas Children's Hospital, Houston, Texas. 3. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. 4. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. 5. Department of Human Development and Family Studies, Penn State University, University Park, Pennsylvania. 6. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.
Abstract
BACKGROUND: Current estimates suggest that 75% of children diagnosed with a central nervous system (CNS) tumor will become 5-year survivors. However, survivors of childhood CNS tumors are at increased risk for long-term morbidity. METHODS: To determine long-term neuropsychological and socioeconomic status (SES) outcomes, adult survivors of pediatric low-grade gliomas (n = 181) in the Childhood Cancer Survivor Study and a sibling comparison group that was frequency-matched by age and sex (n = 105) completed a comprehensive battery of standardized neuropsychological tests and an SES assessment. Multivariable regression models compared treatment-specific groups for neuropsychological and SES outcomes and evaluated associations with tumor location, age at diagnosis, sex, and age at evaluation. RESULTS: In adjusted models, survivors treated with surgery and radiotherapy (surgery+RT; median age at diagnosis, 7 years; median age at assessment, 41 years) scored lower on estimated IQ than survivors treated with surgery only, who scored lower than siblings (surgery+RT, 93.9; surgery only, 101.2; siblings, 108.5; all P values <.0001). Survivors diagnosed at younger ages had low scores for all outcomes (P < .05) except for attention/processing speed. For SES outcomes, survivors treated with surgery+RT had lower occupation scores (odds ratio [OR], 2.6; 95% confidence interval [CI], 1.1-5.9), lower income (OR, 2.6; 95% CI, 1.3-5.0), and less education (OR, 2.1; 95% CI, 1.1-4.0) than those treated with surgery only. CONCLUSIONS: Decades after treatment, survivors treated with radiotherapy and at younger ages had poorer neuropsychological and SES outcomes. Lifelong surveillance of survivors of pediatric low-grade gliomas may be warranted as life events, stages, and transitions (employment, family, and aging) present new challenges and risks.
BACKGROUND: Current estimates suggest that 75% of children diagnosed with a central nervous system (CNS) tumor will become 5-year survivors. However, survivors of childhood CNS tumors are at increased risk for long-term morbidity. METHODS: To determine long-term neuropsychological and socioeconomic status (SES) outcomes, adult survivors of pediatric low-grade gliomas (n = 181) in the Childhood Cancer Survivor Study and a sibling comparison group that was frequency-matched by age and sex (n = 105) completed a comprehensive battery of standardized neuropsychological tests and an SES assessment. Multivariable regression models compared treatment-specific groups for neuropsychological and SES outcomes and evaluated associations with tumor location, age at diagnosis, sex, and age at evaluation. RESULTS: In adjusted models, survivors treated with surgery and radiotherapy (surgery+RT; median age at diagnosis, 7 years; median age at assessment, 41 years) scored lower on estimated IQ than survivors treated with surgery only, who scored lower than siblings (surgery+RT, 93.9; surgery only, 101.2; siblings, 108.5; all P values <.0001). Survivors diagnosed at younger ages had low scores for all outcomes (P < .05) except for attention/processing speed. For SES outcomes, survivors treated with surgery+RT had lower occupation scores (odds ratio [OR], 2.6; 95% confidence interval [CI], 1.1-5.9), lower income (OR, 2.6; 95% CI, 1.3-5.0), and less education (OR, 2.1; 95% CI, 1.1-4.0) than those treated with surgery only. CONCLUSIONS: Decades after treatment, survivors treated with radiotherapy and at younger ages had poorer neuropsychological and SES outcomes. Lifelong surveillance of survivors of pediatric low-grade gliomas may be warranted as life events, stages, and transitions (employment, family, and aging) present new challenges and risks.
Authors: Maryam Fouladi; Elizabeth Gilger; Mehmet Kocak; Dana Wallace; Gray Buchanan; Cara Reeves; Nicole Robbins; Thomas Merchant; Larry E Kun; Raja Khan; Amar Gajjar; Raymond Mulhern Journal: J Clin Oncol Date: 2005-10-01 Impact factor: 44.544
Authors: M Douglas Ris; Karin Walsh; Dana Wallace; F Daniel Armstrong; Emi Holmes; Amar Gajjar; Tianni Zhou; Roger J Packer Journal: Pediatr Blood Cancer Date: 2013-02-26 Impact factor: 3.167
Authors: Christopher D Turner; Christine A Chordas; Cori C Liptak; Celiane Rey-Casserly; Brian L Delaney; Nicole J Ullrich; Liliana C Goumnerova; R Michael Scott; Heather C Begley; William J Fletcher; Xiaopan Yao; Susan Chi; Mark W Kieran Journal: Pediatr Blood Cancer Date: 2009-09 Impact factor: 3.167
Authors: Brenda J Spiegler; Eric Bouffet; Mark L Greenberg; James T Rutka; Donald J Mabbott Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Leslie L Robison; Gregory T Armstrong; John D Boice; Eric J Chow; Stella M Davies; Sarah S Donaldson; Daniel M Green; Sue Hammond; Anna T Meadows; Ann C Mertens; John J Mulvihill; Paul C Nathan; Joseph P Neglia; Roger J Packer; Preetha Rajaraman; Charles A Sklar; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer Journal: J Clin Oncol Date: 2009-04-13 Impact factor: 44.544
Authors: Gregory T Armstrong; Qi Liu; Yutaka Yasui; Sujuan Huang; Kirsten K Ness; Wendy Leisenring; Melissa M Hudson; Sarah S Donaldson; Allison A King; Marilyn Stovall; Kevin R Krull; Leslie L Robison; Roger J Packer Journal: J Natl Cancer Inst Date: 2009-06-17 Impact factor: 11.816
Authors: Alexander G Yearley; Julian Bryan Iorgulescu; Ennio Antonio Chiocca; Pier Paolo Peruzzi; Timothy R Smith; David A Reardon; Michael A Mooney Journal: Neurooncol Adv Date: 2022-06-24
Authors: Michaela Schuermann; Yvonne Dzierma; Frank Nuesken; Joachim Oertel; Christian Rübe; Patrick Melchior Journal: Front Neurol Date: 2022-01-14 Impact factor: 4.003